MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC
Bisheng Huang1, Wei Zhai1, Guanghui Hu1
1Department of Urology, Shanghai Tenth People's Hospital, Tongji University 301 Yanchang Road, Shanghai 200072, China.
Abstract:
Accumulating evidence suggested that microRNA (miRNA) plays important regulatory roles in the initiation and development of various cancers. Previous study showed that microRNA-206 (miR-206) is dysregulated in human bladder cancer tissues, however, the biological function and underlying mechanisms of miR-206 in human bladder cancer remain unknown. In the present study, we aimed to investigate the clinical significance of miR-206 and its target gene YRDC in human bladder cancer, and to determine its effects on oncogenic phenotypes of this disease. Our results showed that miR-206 expression was downregulated significantly in bladder cancer tissues and cell lines compared with adjacent normal bladder tissues and human bladder epithelial immortalized SV-HUC-1 cell line, respectively. Overexpression of miR-206 reduced the expression of YRDC and inhibited bladder cancer cell proliferation, colony formation, migration, invasion and induced cell cycle arrest at G0/G1 phase. In addition, knockdown of YRDC exhibited similar effects with miR-206 overexpression in bladder cancer cells and restoration of YRDC partially reversed the effects of miR-206 in bladder cancer cells. These findings indicated that mir-206 might be a novel target for bladder cancer therapy by targeting YRDC.
Insights
MicroRNA-206 (miR-206) is downregulated in bladder cancer, inhibiting tumor growth and spread by targeting YRDC. Restoring miR-206 shows therapeutic potential for bladder cancer by regulating YRDC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are key regulators in cancer development.
- MicroRNA-206 (miR-206) is dysregulated in human bladder cancer, but its function is unclear.
Purpose of the Study:
- Investigate the clinical significance of miR-206 in human bladder cancer.
- Determine the effects of miR-206 and its target YRDC on bladder cancer phenotypes.
Main Methods:
- Compared miR-206 expression in bladder cancer tissues/cell lines versus normal tissues/cells.
- Overexpressed miR-206 and knocked down YRDC in bladder cancer cells.
- Assessed effects on cell proliferation, colony formation, migration, invasion, and cell cycle.
Main Results:
- miR-206 was significantly downregulated in bladder cancer.
- miR-206 overexpression inhibited bladder cancer cell proliferation, migration, invasion, and induced G0/G1 cell cycle arrest.
- Knockdown of YRDC mimicked miR-206 effects, and YRDC restoration partially reversed them.
Conclusions:
- miR-206 acts as a tumor suppressor in human bladder cancer by targeting YRDC.
- miR-206 may serve as a novel therapeutic target for bladder cancer treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


